Treatment choices and targets in Type 2 diabetes and chronic kidney disease

被引：0
|
作者：
Lomova-Williams, L. [1 ]
Mallipedhi, A. [1 ,2 ]
Benjamin, S. [1 ]
Price, D. E. [1 ]
Stephens, J. W. [1 ,2 ]
机构：
[1] Abertawe Bro Morgannwg Univ Hlth Board, Dept Endocrinol & Diabet, Morriston Hosp, Swansea, W Glam, Wales
[2] Swansea Univ, Diabet Res Grp, Inst Life Sci, Swansea, W Glam, Wales
来源：
DIABETIC MEDICINE | 2013年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：162 / 162
页数：1
相关论文
共 50 条
  • [41] Biomarkers of rapid chronic kidney disease progression in type 2 diabetes
    Looker, Helen C.
    Colombo, Marco
    Hess, Sibylle
    Brosnan, Mary J.
    Farran, Bassam
    Dalton, R. Neil
    Wong, Max C.
    Turner, Charles
    Palmer, Colin N. A.
    Nogoceke, Everson
    Groop, Leif
    Salomaa, Veikko
    Dunger, David B.
    Agakov, Felix
    McKeigue, Paul M.
    Colhoun, Helen M.
    [J]. KIDNEY INTERNATIONAL, 2015, 88 (04) : 888 - 896
  • [42] Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes
    Rodriguez-Poncelas, Antonio
    Mundet-Tuduri, Xavier
    Miravet-Jimenez, Sonia
    Casellas, Aina
    Barrot-De la Puente, Joan F.
    Franch-Nadal, Josep
    Coll-de Tuero, Gabriel
    [J]. PLOS ONE, 2016, 11 (02):
  • [43] Prevalence of Chronic Kidney Disease in Adults with Type 2 Diabetes Mellitus
    Low, Serena K. M.
    Sum, Chee Fang
    Yeoh, Lee Ying
    Tavintharan, Subramaniam
    Ng, Xiao Wei
    Lee, Simon B. M.
    Tang, Wern Ee
    Lim, Su Chi
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2015, 44 (05) : 164 - 171
  • [44] Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes Reply
    Bakris, George L.
    Agarwal, Rajiv
    Filippatos, Gerasimos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11):
  • [45] Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Bakris, George L.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Joseph, Amer
    Filippatos, Gerasimos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23): : 2219 - 2229
  • [46] DIABETES MELLITUS TYPE 2 AND CHRONIC KIDNEY DISEASE PROGRESSION IS THERE A DIFFERENCE?
    Stefan, Gabriel
    Petrescu, Ligia
    Halip, Alexandru
    Mircescu, Gabriel
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [47] Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
    Fu, Edouard L.
    Kutz, Alexander
    Desai, Rishi J.
    [J]. KIDNEY INTERNATIONAL, 2023, 103 (01) : 30 - 33
  • [48] Finerenone in patients with chronic kidney disease and type 2 diabetes mellitus
    Wanner, C.
    Nitschmann, S.
    [J]. INTERNIST, 2021, 62 (05): : 577 - 580
  • [49] HEPATIC STEATOSIS IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
    Adrian, Therese
    Hornum, Mads
    Knop, Filip K.
    Almdal, Thomas Peter
    Rossing, Peter
    Lida, Lisa
    Heinrich, Niels Sondergaard
    Boer, Vincent
    Marsman, Anouk
    Petersen, Esben
    Siebner, Hartwig
    Feldt-Rasmussen, Bo
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I294 - I294
  • [50] Effects of Alogliptin in Chronic Kidney Disease Patients with Type 2 Diabetes
    Sakai, Yukinao
    Suzuki, Anna
    Mugishima, Koji
    Sumi, Yuichiro
    Otsuka, Yusuke
    Otsuka, Tomoyuki
    Ohno, Dai
    Murasawa, Tsuneo
    Tsuruoka, Shuichi
    [J]. INTERNAL MEDICINE, 2014, 53 (03) : 195 - 203
12345